41 related articles for article (PubMed ID: 7606731)
1. Pretubulysin: from hypothetical biosynthetic intermediate to potential lead in tumor therapy.
Herrmann J; Elnakady YA; Wiedmann RM; Ullrich A; Rohde M; Kazmaier U; Vollmar AM; Müller R
PLoS One; 2012; 7(5):e37416. PubMed ID: 22616003
[TBL] [Abstract][Full Text] [Related]
2. (-)-Rhazinilam and the diphenylpyridazinone NSC 613241: Two compounds inducing the formation of morphologically similar tubulin spirals but binding apparently to two distinct sites on tubulin.
Bai R; Hamel E
Arch Biochem Biophys; 2016 Aug; 604():63-73. PubMed ID: 27311615
[TBL] [Abstract][Full Text] [Related]
3. Stabilizing versus destabilizing the microtubules: a double-edge sword for an effective cancer treatment option?
Fanale D; Bronte G; Passiglia F; Calò V; Castiglia M; Di Piazza F; Barraco N; Cangemi A; Catarella MT; Insalaco L; Listì A; Maragliano R; Massihnia D; Perez A; Toia F; Cicero G; Bazan V
Anal Cell Pathol (Amst); 2015; 2015():690916. PubMed ID: 26484003
[TBL] [Abstract][Full Text] [Related]
4. Bioactive peptides and depsipeptides with anticancer potential: sources from marine animals.
Suarez-Jimenez GM; Burgos-Hernandez A; Ezquerra-Brauer JM
Mar Drugs; 2012 May; 10(5):963-986. PubMed ID: 22822350
[TBL] [Abstract][Full Text] [Related]
5. Application of a water-soluble pyridyl disulfide amine linker for use in Cu-free click bioconjugation.
Thomas JD; Burke TR
Tetrahedron Lett; 2011 Aug; 52(33):4316-4319. PubMed ID: 21826118
[TBL] [Abstract][Full Text] [Related]
6. Intracellular activation and deactivation of tasidotin, an analog of dolastatin 15: correlation with cytotoxicity.
Bai R; Edler MC; Bonate PL; Copeland TD; Pettit GR; Ludueña RF; Hamel E
Mol Pharmacol; 2009 Jan; 75(1):218-26. PubMed ID: 18927208
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the interaction of TZT-1027, a potent antitumor agent, with tubulin.
Natsume T; Watanabe J; Tamaoki S; Fujio N; Miyasaka K; Kobayashi M
Jpn J Cancer Res; 2000 Jul; 91(7):737-47. PubMed ID: 10920282
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of human colon cancer cells changes the expression of beta-tubulin isotypes and MAPs.
Carles G; Braguer D; Dumontet C; Bourgarel V; Gonçalves A; Sarrazin M; Rognoni JB; Briand C
Br J Cancer; 1999 Jun; 80(8):1162-8. PubMed ID: 10376967
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer therapies in development. A review of their pharmacology and clinical potential.
de Valeriola D; Awada A; Roy JA; Di Leo A; Biganzoli L; Piccart M
Drugs; 1997 Sep; 54(3):385-413. PubMed ID: 9279502
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of TZT-1027, a novel dolastatin 10 derivative.
Kobayashi M; Natsume T; Tamaoki S; Watanabe J; Asano H; Mikami T; Miyasaka K; Miyazaki K; Gondo M; Sakakibara K; Tsukagoshi S
Jpn J Cancer Res; 1997 Mar; 88(3):316-27. PubMed ID: 9140117
[TBL] [Abstract][Full Text] [Related]
11. A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors.
Tahir SK; Han EK; Credo B; Jae HS; Pietenpol JA; Scatena CD; Wu-Wong JR; Frost D; Sham H; Rosenberg SH; Ng SC
Cancer Res; 2001 Jul; 61(14):5480-5. PubMed ID: 11454695
[TBL] [Abstract][Full Text] [Related]
12. Natural organic compounds that affect to microtubule functions.
Iwasaki S
Yakugaku Zasshi; 1998 Apr; 118(4):112-26. PubMed ID: 9564789
[TBL] [Abstract][Full Text] [Related]
13. Recent developments in tubulin polymerization inhibitors: An overview.
Kaur R; Kaur G; Gill RK; Soni R; Bariwal J
Eur J Med Chem; 2014 Nov; 87():89-124. PubMed ID: 25240869
[TBL] [Abstract][Full Text] [Related]
14. LU103793 (NSC D-669356): a synthetic peptide that interacts with microtubules and inhibits mitosis.
de Arruda M; Cocchiaro CA; Nelson CM; Grinnell CM; Janssen B; Haupt A; Barlozzari T
Cancer Res; 1995 Jul; 55(14):3085-92. PubMed ID: 7606731
[TBL] [Abstract][Full Text] [Related]
15. Spongistatin 1, a highly cytotoxic, sponge-derived, marine natural product that inhibits mitosis, microtubule assembly, and the binding of vinblastine to tubulin.
Bai R; Cichacz ZA; Herald CL; Pettit GR; Hamel E
Mol Pharmacol; 1993 Oct; 44(4):757-66. PubMed ID: 8232226
[TBL] [Abstract][Full Text] [Related]
16. Suppression of microtubule dynamics by binding of cemadotin to tubulin: possible mechanism for its antitumor action.
Jordan MA; Walker D; de Arruda M; Barlozzari T; Panda D
Biochemistry; 1998 Dec; 37(50):17571-8. PubMed ID: 9860873
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]